A U.S. Food and Drug Administration (FDA) advisory panel voted Friday against approval of Pfizer (PFE)/BioNTech’s (BNTX) third dose for the U.S.
The vote comes after a heated debate in recent weeks over the need for booster or additional shots, which both mRNA companies — Pfizer and Moderna (MRNA) — have advocated for.
Dr. Peter Marks, the FDA’s leading expert on vaccines, touched on the controversy in his introductory remarks.
“We know that there may be differing opinions of the…
Source link
